Search research articles
Contact Us
Filters
Showing results (641-650 of 661) with videos related to
Page
of 67
Sort By:
American Journal of Hematology
|
February 14, 2020
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma
John Timmerman, Charles Herbaux, Vincent Ribrag, et al.
National Science Review
|
December 15, 2022
Unimodal productivity-biodiversity relationship along the gradient of multidimensional resources across Chinese grasslands
Yanfen Wang, Jianqing Du, Zhe Pang, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
April 15, 2018
Frequency of hepatitis B surface antigen variants (HBsAg) in hepatitis B virus genotype B and C infected East- and Southeast Asian patients: Detection by the Elecsys<sup>®</sup> HBsAg II assay
Hyon Suk Kim, Xinyue Chen, Min Xu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 25, 2025
External Validation of the GOLDEN Model for Predicting HBsAg Loss in Noncirrhotic Chronic Hepatitis B Patients With Interferon-Alpha-Based Therapy
Xingmei Liao, Qing Xie, Xiaoguang Dou, et al.
Gut
|
June 20, 2024
High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
Rong Fan, Siru Zhao, Junqi Niu, et al.
Cancer Discovery
|
October 18, 2022
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
Guy Jerusalem, Yeon Hee Park, Toshinari Yamashita, et al.
JAMA Oncology
|
November 8, 2019
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors: A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical Trial
Kimberley M Heinhuis, Matteo Carlino, Markus Joerger, et al.
Hepatology International
|
December 9, 2025
Efficacy and safety of entecavir, peginterferon alfa-2b and GM-CSF combination therapy: the anchor randomized controlled trial
Di Wu, Da Huang, Shifang Peng, et al.
The Journal of Antimicrobial Chemotherapy
|
September 24, 2024
Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus
Wenhang Yang, Xue Li, Jiawei Chen, et al.
Protein & Cell
|
January 11, 2018
Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs
Yi Yang, Han Wu, Xiangjin Kang, et al.
Page
of 67
Search research articles
Search
Showing results (641-650 of 661) with videos related to
Sort By:
Page
of 67
American Journal of Hematology
|
February 14, 2020
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma
John Timmerman, Charles Herbaux, Vincent Ribrag, et al.
National Science Review
|
December 15, 2022
Unimodal productivity-biodiversity relationship along the gradient of multidimensional resources across Chinese grasslands
Yanfen Wang, Jianqing Du, Zhe Pang, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
April 15, 2018
Frequency of hepatitis B surface antigen variants (HBsAg) in hepatitis B virus genotype B and C infected East- and Southeast Asian patients: Detection by the Elecsys<sup>®</sup> HBsAg II assay
Hyon Suk Kim, Xinyue Chen, Min Xu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 25, 2025
External Validation of the GOLDEN Model for Predicting HBsAg Loss in Noncirrhotic Chronic Hepatitis B Patients With Interferon-Alpha-Based Therapy
Xingmei Liao, Qing Xie, Xiaoguang Dou, et al.
Gut
|
June 20, 2024
High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
Rong Fan, Siru Zhao, Junqi Niu, et al.
Cancer Discovery
|
October 18, 2022
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
Guy Jerusalem, Yeon Hee Park, Toshinari Yamashita, et al.
JAMA Oncology
|
November 8, 2019
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors: A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical Trial
Kimberley M Heinhuis, Matteo Carlino, Markus Joerger, et al.
Hepatology International
|
December 9, 2025
Efficacy and safety of entecavir, peginterferon alfa-2b and GM-CSF combination therapy: the anchor randomized controlled trial
Di Wu, Da Huang, Shifang Peng, et al.
The Journal of Antimicrobial Chemotherapy
|
September 24, 2024
Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus
Wenhang Yang, Xue Li, Jiawei Chen, et al.
Protein & Cell
|
January 11, 2018
Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs
Yi Yang, Han Wu, Xiangjin Kang, et al.
Page
of 67